Kathryn Saegert

Kathryn Saegert has a diverse work experience in the financial and healthcare sectors. Kathryn is currently serving as the Director of Financial Planning and Analysis at Mission Therapeutics since 2021. Prior to this, they worked at Mission Therapeutics as a Finance Business Partner from 2021 until 2023.

Before joining Mission Therapeutics, Kathryn held positions at PwC. Kathryn worked as a Deals Senior Associate from July 2018 to December 2020 and as a Deals and Assurance Associate from September 2016 to June 2018.

Additionally, Kathryn has experience as a Locum Pharmacist at various institutions, including the Royal Brompton and Harefield NHS Trust, where they primarily worked with the electronic prescribing team to implement electronic prescribing in pediatric services. Kathryn also covered multiple wards at Great Ormond Street Hospital, specializing in endocrinology, gastrointestinal medicine, and renal diseases.

Their career in healthcare started at Great Ormond Street Hospital, where they served as a Resident Pharmacist from October 2014 to April 2016 and as a Pre-Registration Pharmacist from July 2013 to July 2014.

Kathryn Saegert's education history includes earning a degree in Pharmacy from the University of Bath between the years of 2009 and 2013. Following this, they pursued further education at ICAEW from 2016 to 2019, focusing on ACA studies.